Jennita Slomp

High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

Monique Terwijn, Wim L.J. van Putten, Angèle Kelder et al. · Journal of Clinical Oncology · 2013 · 449 citations · Full text

Medicine, Hematology, Oncology +16

Antibodies to PAI-1 alter the invasive and migratory properties of human tumour cells in vitro

Teresa Brooks, Jennita Slomp, Paul H.A. Quax et al. · Clinical & Experimental Metastasis · 2000 · 48 citations

Medicine, Cell Biology, Oncology +13

Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2C9 genotype

Arian Plat, Alieke A C van Dijk, Margriet Piersma‐Wichers et al. · Thrombosis and Haemostasis · 2003 · 45 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible?

Rik A. Brooimans, Vincent H. J. van der Velden, Nancy Boeckx et al. · Leukemia Research · 2018 · 31 citations · Full text

Medicine, Hematology, Oncology +12